The maximum score of arthritis in recipient rats which received 0.3 mg mycobacterial adjuvant immediately after cell transfer. The cells were obtained from popliteal lymph nodes draining the injection site of 0.003 mg of this adjuvant 4- 16 Figure 3 . The clinical scores of arthritis in male rats (6--8 in each group) rechallenged with 0.3 mg mycobacterial adjuvant at 2-4 weeks after the primary challenge with 0.003 mg of this adjuvant. Castration was performed 2 weeks before priming. A testosterone pellet was implanted 2 days after castration and removed 7 days after priming.
Discussion. Unresponsiveness to mycobacterial adjuvant is due to an inhibitory response by suppressor cells, presumably T cells 4'5. The present study indicated that male rats were more resistant than female rats in the induction of unresponsiveness in highly susceptible DA rats. The induction time of unresponsiveness in male rats shifted toward the female type after castration. An application of testosterone to castrated male rats could revert the induction time to the male type. Testosterone removed before priming had no such restorative effect. This suggests that testosterone acts suppressively on the kinetics of the development of suppressor cells. However, the definitive clarification of the mechanisms of testosterone action on suppressor cells must await further study. The transfer study also presented evidence indicating a sex difference in the incubation time for the development of suppressor cells. Although genetic control of the susceptibility to AA has been reported by other investigators 7'8, the present study suggests that testosterone could be a factor modulating the manifestation of this disease. Modulation of the expression of autoimmunity by androgen action on the thymicdependent regulatory mechanisms has been reported in MRL/ lpr and NZB x NZW Fl mice 9,~0. 
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Summary. Male Fischer F-344 rats were given ethanol in the drinking water and/or by single oral administration. Following this, the animals received p.o. 100 ng/kg of the hepatocarcinogen [JH]aflatoxin B l (AFB 0. 24 h later, the level of DNA-bound AFB1 was determined in the liver and was found not to be affected by any type of ethanol pretreatment. A cocarcinogenic effect of ethanol in the liver is therefore unlikely to be due to an effect on the metabolic activation and inactivation processes governing the formation of DNA-binding AFB1 metabolites.
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Although alcohol is listed as a factor contributing to between 2 and 4% of all human cancer deaths 4, pure ethanol has so far yielded negative results in animal tests for carcinogenicity (reported in Obe and RistowS). Alcohol must therefore be considered to be a cofactor in the etiology of cancer 6. One of the mechanisms postulated to explain its cocarcinogenic activity is the ability of ethanol to interact with drug-metabolizing enzyme systems involved in the activation of procarcinogens to reactive, DNA-binding intermediates. Enzyme activities can either be induced after repeated administration of ethanol or be inhibited by ethanol itself (see reviews by Lieber et al.
and McCoy et al.S).
The susceptibility of the enzymes to this latter effect seems to be organ-specific, as it has recently been found that the first-pass clearance of dimethyl-or diethylnitrosamine 9 and of methylbenzylnitrosamine 1~ is inhibited by ethanol in the liver but not in the oesophagus. These results might explain mechanistically some of the results describing a modulation of nitrosamine carcinogenesis by ethanol (Lieber et al. In each experiment, two control rats received water instead of alcohol. 24 h after the administration of the carcinogen, the animals were killed by an overdose of ether and the livers were excised. DNA was isolated as described 21 and the specific radioactivity was determined. Acid treatment of the DNA to liberate the purines and reverse-phase HPLC of the hydrolysate 22 revealed that the radioactivity did not co-elute with the optical density of adenine or guanine but appeared without optical density at later positions known to contain the more lipophilic purine-aflatoxin adducts 23. All DNA radioactivity therefore represented cova- 
wt).
Results and discussion. The covalent binding of aflatoxin B 1 to liver DNA of the six untreated rats (two in each experiment A, B, and C) resulted in a CBI value of 13,500 =1:700 (1 SD), in good agreement with the values determined earlier 19. None of the pretreatment regimens with ethanol resulted in a dose-dependent change ( fig.) . Statistical analysis of the data with Spearman's rank correlation coefficient revealed a p < 0.1 with respect to a decrease in DNA binding in experiment C, but only up to a single ethanol dose of 2 g/kg DNA. The CBI obtained after 4 g/kg was almost back to control values. Pretreatment for 10 days (experiment A) revealed a tendency towards an increase, but, again, the highest dose tested gave rise to normal values. It was not surprising then to see that the combination of chronic and acute ethanol treatment (experiment B) balanced out the two trends mentioned above. The higher CBI at 2% ethanol in the drinking water plus 2 g/kg acute dose was due to only one single high value which was more than four SD above the mean calculated from the other nine values determined in this experiment. AFB 1 can be oxidized in a variety of positions 24. Only one of these possibilities, the epoxidation of the 2, 3-double bond, leads to the formation of a reactive DNA-binding metabolite 23. Our data indicate that a 10-day pretreatment with ethanol did not induce the respective enzyme activities in such a way as to change the concentration of the reactive AFB:2, 3-oxide near the DNA after administration of a low dose of AFBj. As opposed to the inducing effect of chronic ethanol treatment on the metabolism of various xenobiotics 7, ethanol itself has been shown to be a competitive inhibitor of the metabolism of many aromatic and chlorinated hydrocarbons 2s. Our experiment C did not reveal any dose-dependent effect of a single dose of ethanol on the formation of DNA-binding metabolites of AFB~ in liver. The slight reduction shown up to 2 g/kg cannot be taken as an indication for an effect because it would be difficult to explain why the highest ethanol dose used should be less effective if a competitive inhibition is assumed to be the basis for this observation.
Our results provide in vivo evidence that a putative cocarcinogenic activity of alcohol on aflatoxin-induced liver tumor induction at low dose levels is unlikely to be due to a modulation of the initial DNA damage and repair within 24 h. Other mechanisms of cocarcinogenic action, such as cytotoxicity and the regenerative processes elicited 26-28, changes in DNA repair or alcoholmediated genotoxicity via aldehydes and oxygen radicals s might play a more important role than changes of enzymatic activities. This lack of an observable effect, shown both for single and repeated alcohol administrations, contrasts with some positive results reported for nitrosamines 7 9. The discrepancy shows that the modulations are probably specific for the structure of the carcinogen H, for the target organ ~3, and for the dose levels used both of carcinogen and of ethanoP 2. Any one single experimental system will therefore not be able to describe in full the complex role of alcohol in chemical carcinogenesis.
